source stringlengths 2 222 | date stringlengths 19 19 | url stringlengths 22 853 ⌀ | text stringlengths 0 10k ⌀ | title stringlengths 0 701 | context_id stringlengths 1 9 | document_id stringclasses 2
values | document_type stringclasses 2
values |
|---|---|---|---|---|---|---|---|
Zacks Investment Research | 2021-01-11 18:48:10 | https://www.zacks.com/stock/news/1244751/abbvie-abbv-gains-as-market-dips-what-you-should-know | AbbVie (ABBV) closed at $109.02 in the latest trading session, marking a +1.63% move from the prior day. | AbbVie (ABBV) Gains As Market Dips: What You Should Know | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2021-01-11 12:20:41 | https://investorplace.com/2021/01/7-hot-stocks-that-will-keep-you-energized-with-three-percent-plus-yields/ | These hot stocks combine healthy dividends with lasting brand names, making them some of the smartest picks on the market. The post 7 Hot Stocks That Will Keep You Energized With 3%-Plus Yields appeared first on InvestorPlace. | 7 Hot Stocks That Will Keep You Energized With 3%-Plus Yields | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-01-10 22:11:33 | https://seekingalpha.com/article/4398152-dividend-diligence-on-abbvie-seeking-alpha | Dividend Diligence On AbbVie With Seeking Alpha | Dividend Diligence On AbbVie With Seeking Alpha | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2021-01-09 06:10:00 | https://www.fool.com/investing/2021/01/09/how-safe-is-abbvies-dividend/ | Don't jump to a conclusion too quickly. | How Safe Is AbbVie's Dividend? | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2021-01-09 06:07:00 | https://www.fool.com/investing/2021/01/09/3-stocks-that-are-absurdly-cheap-right-now/ | They trade at low earnings multiples and could be excellent buys for 2021. | 3 Stocks That Are Absurdly Cheap Right Now | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GuruFocus | 2021-01-08 10:18:02 | https://www.gurufocus.com/news/1326833/3-low-forward-priceearnings-ratio-stock-picks | The three securities listed below could be of interest to investors, as their forward price-earnings ratios are lower than the S&P 500's historical average of 15. The projections of future earnings are based on data from Morningstar analysts. | 3 Low Forward Price-Earnings Ratio Stock Picks | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-01-08 09:47:21 | https://www.zacks.com/stock/news/1243400/abbvies-abbv-skyrizi-succeeds-in-crohns-disease-studies | AbbVie's (ABBV) Skyrizi achieves improvements in clinical remission and endoscopic response in phase III studies in moderate to severe Crohn's disease patients. | AbbVie's (ABBV) Skyrizi Succeeds in Crohn's Disease Studies | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2021-01-07 15:58:34 | https://investorplace.com/2021/01/7-safe-stocks-to-buy-to-start-off-the-year/ | These safe stocks to buy have a low beta, attractive valuation and healthy dividends. Get in early this year to strengthen your portfolio. | 7 Safe Stocks to Buy to Start Off the Year | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-01-07 13:38:11 | https://seekingalpha.com/article/4397775-8-dividend-increases-to-start-2021 | All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. An average increase of 8.4% and a median increase of 6.6%. | 8 Dividend Increases To Start 2021 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-01-07 09:47:19 | https://www.zacks.com/stock/news/1242420/3-biotech-technological-developments-to-watch-out-for-in-2021 | Here we discuss three booming technological developments in the biotech sector, which can capture investor attention in 2021 | 3 Biotech Technological Developments to Watch Out For in 2021 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
PRNewsWire | 2021-01-07 08:45:00 | https://www.prnewswire.com/news-releases/risankizumab-skyrizi-demonstrates-significant-improvements-in-clinical-remission-and-endoscopic-response-in-two-phase-3-induction-studies-in-patients-with-crohns-disease-301202802.html | NORTH CHICAGO, Ill., Jan. 7, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive results from two Phase 3 induction studies, ADVANCE and MOTIVATE, showing both doses of risankizumab (600 mg and 1200 mg) met both primary endpoints of clinical remission and endoscopic response... | Risankizumab (SKYRIZI®) Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn's Disease | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GuruFocus | 2021-01-06 11:17:17 | https://www.gurufocus.com/news/1324739/4-highyield-stocks-to-ring-in-the-new-year | Due to gains made over the past few years and our focus on building up our lower-yielding positions, the yield on the portfolio my wife and I are building fell to just over 2% last year. One of the goals that I listed for our portfolio in 2021 was to increase the average yield of our holdings. | 4 High-Yield Stocks to Ring in the New Year | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-01-06 11:17:12 | https://www.zacks.com/stock/news/1241891/abbvies-abbv-skyrizi-succeeds-in-psoriatic-arthritis-studies | AbbVie's (ABBV) Skyrizi achieves improvements in disease activity across joint and skin symptoms in phase III studies in active psoriatic arthritis. | AbbVie's (ABBV) Skyrizi Succeeds in Psoriatic Arthritis Studies | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
CNBC Television | 2021-01-05 19:21:48 | https://www.youtube.com/watch?v=nt4pXWBC_Zc | Forget the bond market. If you want income, you need to find it in stocks, the "Mad Money" host said. | Jim Cramer: Dividend stock picks with potential market upside | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-01-05 18:48:14 | https://www.zacks.com/stock/news/1241541/abbvie-abbv-outpaces-stock-market-gains-what-you-should-know | AbbVie (ABBV) closed at $106.50 in the latest trading session, marking a +1.03% move from the prior day. | AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2021-01-05 07:40:00 | https://www.fool.com/investing/2021/01/05/got-1000-these-2-top-stocks-can-make-you-rich/ | These two pharmaceutical stocks can significantly boost your wealth in the long run. | Got $1,000? These 2 Top Stocks Can Make You Rich | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2021-01-04 12:03:29 | https://investorplace.com/2021/01/7-cheap-stocks-to-buy-in-january-for-a-quick-buck/ | 2020 has taken the market capitalizations of many strong companies to lows. That means there are some great options for cheap stocks to buy in January. | 7 Cheap Stocks to Buy in January For a Quick Buck | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-01-04 08:05:48 | https://seekingalpha.com/article/4397165-abbvies-fair-value-is-least-147-per-share | ABBV's shares have rallied hard in recent weeks. But the market is still pricing in at least a partial failure of Humira replacements. | AbbVie's Fair Value Is At Least $147 Per Share | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GuruFocus | 2021-01-03 16:38:14 | https://www.gurufocus.com/news/1321708/2020-portfolio-review-what-a-year | Without a doubt, 2020 will be a year few will ever forget. A global pandemic upended normal life for so many people. | 2020 Portfolio Review: What a Year | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2021-01-01 07:04:00 | https://www.fool.com/investing/2021/01/01/these-4-micro-cap-healthcare-stocks-gained-the-mos/ | Innovation paid off big for investors. | These 4 Micro-Cap Healthcare Stocks Gained the Most in 2020 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GuruFocus | 2020-12-31 15:30:38 | https://www.gurufocus.com/news/1321145/warren-buffetts-top-5-holdings-post-mixed-performances-in-2020 | With the final day of an interesting and memorable year upon us, investors are looking at their portfolios to determine how they performed in 2020. | Warren Buffett's Top 5 Holdings Post Mixed Performances in 2020 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-12-31 13:40:47 | https://seekingalpha.com/article/4396860-top-10-undervalued-high-yield-income-stocks-for-2021 | 2021 could be a year in which value stocks outperform. Income potential remains a key theme for 2021 and beyond, as interest rates remain at record lows. | Top 10 Undervalued High-Yield Income Stocks For 2021 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-12-31 08:15:00 | https://www.fool.com/investing/2020/12/31/3-stocks-that-can-pay-you-more-than-social-securit/ | Boost your retirement income with these stocks. | 3 Stocks That Can Pay You More Than Social Security Benefits | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-12-31 07:22:00 | https://www.fool.com/investing/2020/12/31/3-warren-buffett-stocks-worth-buying-now/ | Here are three great stocks to buy if you want to invest like the Oracle of Omaha. | 3 Warren Buffett Stocks Worth Buying Now | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-12-31 06:33:00 | https://www.fool.com/investing/dividends-income/2020/12/31/how-to-find-the-best-dividend-stocks/ | It's hard to beat dividends -- they offer reliable (and growing) income, inflation protection, and support in retirement. | How to Find the Best Dividend Stocks | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-12-30 06:12:43 | https://seekingalpha.com/article/4396693-2-top-picks-safe-high-dividend-biotechs-for-2021 | The elusive conjunction of safety and growing yield is a holy grail for many investors. Seeking Alpha's quant system screens seven larger large cap biotech stocks with dividends ranging from 3.16% to 5.04%. | 2 Top Picks - Safe High Dividend Biotechs For 2021 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-12-29 23:13:24 | https://seekingalpha.com/article/4396673-i-replaced-jumbo-cd-this-eclectic-portfolio-of-value-conscious-dividend-paying-stocks | Like many conservative investors I prefer to put my fixed income into a 5 year CD ladder but this year's near 0% rates have changed my strategy. Since May I have built a portfolio of defensive dividend stocks intended to replace a 5 year CD I couldn't face rolling over at today's 1.30% rate. | I Replaced A Jumbo CD With This Eclectic Portfolio Of Value-Conscious Dividend-Paying Stocks | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-12-29 19:19:16 | https://seekingalpha.com/article/4396667-undervalued-pharmaceutical-dividends-for-new-year | AbbVie and Bristol-Myers Squibb are major pharmaceuticals that have recently made large acquisitions that have significantly increased their total debt. However, both AbbVie and Bristol-Myers Squibb have robust drug pipelines and are actively expanding indications of key therapeutics to drive strong growth going forwar... | Undervalued Pharmaceutical Dividends For The New Year | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2020-12-29 18:48:22 | https://www.zacks.com/stock/news/1232099/abbvie-abbv-gains-as-market-dips-what-you-should-know | AbbVie (ABBV) closed at $104.70 in the latest trading session, marking a +1.21% move from the prior day. | AbbVie (ABBV) Gains As Market Dips: What You Should Know | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-12-29 09:00:00 | https://seekingalpha.com/article/4396488-2-ideas-for-yield-hunting-in-2021-what-i-added-to-watchlist | AbbVie and VICI Properties have earned a spot on my 2021 dividend watchlist which consists of companies I am considering adding to my dividend income portfolio. AbbVie has a strong pipeline of medicines across Phase 1, 2, 3, and Submitted stages which should fuel future growth and generate additional income to its bott... | 2 Ideas For Yield Hunting In 2021, What I Added To The Watchlist | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-12-29 07:51:00 | https://www.fool.com/investing/2020/12/29/have-600-and-10-years-to-wait-park-it-in-these-3-t/ | Here are three great stocks positioned to outperform for patient investors. | Have $600 and 10 Years to Wait? Park It in These 3 Top Stocks | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-12-29 06:04:00 | https://www.fool.com/investing/2020/12/29/3-stocks-thatll-turn-your-600-stimulus-check-into/ | These stocks should provide solid dividends you can count on. | 3 Stocks That'll Turn Your $600 Stimulus Check Into a Money Machine | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-12-28 16:41:29 | https://seekingalpha.com/article/4396517-3-stocks-to-buy-and-hold-forever | Buying momentum in AT&T faded, as expected, as investors lost interest in its streaming subscription growth. Markets ignoring dividend-income stocks, as stock performance overshadows their strong margins. | 3 A+ Stocks To Buy And Hold Forever | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2020-12-28 10:32:11 | https://www.zacks.com/stock/news/1225143/abbvie-abbv-outperforms-industry-year-to-date-heres-why | AbbVie's (ABBV) key drug, Humira is seeing strong demand in the United States while generics are eroding ex-U.S. sales. New drugs, Skyrizi and Rinvoq are seeing strong sales uptake. | AbbVie (ABBV) Outperforms Industry Year to Date: Here's Why | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-12-25 06:08:00 | https://www.fool.com/investing/2020/12/25/got-5000-these-3-stocks-are-ridiculously-cheap-rig/ | All three also offer attractive dividends. | Got $5,000? These 3 Stocks Are Ridiculously Cheap Right Now | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
24/7 Wall Street | 2020-12-24 08:28:28 | https://247wallst.com/investing/2020/12/24/5-highest-yielding-dividend-aristocrat-stocks-to-buy-now-for-2021/ | With 2020 thankfully almost over, many investors are looking to next year. While there is some hope that a return to normal could be achieved by the summer, one thing is for sure: the stock market is very overbought and some of the momentum stock trades are very crowded and could be poised to get hit hard. | 5 Highest-Yielding Dividend Aristocrat Stocks to Buy Now for 2021 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-12-23 07:25:00 | https://www.fool.com/investing/2020/12/23/3-stocks-to-buy-with-dividends-yielding-more-than/ | From a recession-proof stock to an out-of-favor oil play, these high dividend yielders could make you a lot of money. | 3 Stocks to Buy With Dividends Yielding More Than 4% | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-12-23 06:50:00 | https://www.fool.com/investing/2020/12/23/coronavirus-stimulus-checks-top-stocks-to-buy-now/ | $600 is enough to purchase a small stream of dividend income in a leading company. | Coronavirus Stimulus Checks: Top Stocks To Buy Now | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2020-12-22 18:48:09 | https://www.zacks.com/stock/news/1197532/abbvie-abbv-dips-more-than-broader-markets-what-you-should-know | AbbVie (ABBV) closed at $102.80 in the latest trading session, marking a -0.88% move from the prior day. | AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2020-12-22 17:18:03 | https://www.zacks.com/stock/news/1197206/3-stocks-with-strong-dividends-to-buy-for-growth-in-2021 | Investors might want to consider adding stocks to their 2021 portfolios that pay a solid dividend and provide exposure to growth areas. | 3 Stocks with Strong Dividends to Buy for Growth in 2021 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GuruFocus | 2020-12-22 16:11:11 | https://www.gurufocus.com/news/1317010/5-health-care-stocks-outperforming-the-benchmark | According to the GuruFocus All-in-One Screener, a Premium feature, the following guru-owned health care stocks have outperformed the S&P 500 Index over the past 12 months through Dec. 22. | 5 Health Care Stocks Outperforming the Benchmark | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2020-12-22 09:47:27 | https://www.zacks.com/stock/news/1195445/are-options-traders-betting-on-a-big-move-in-abbvie-abbv-stock | Investors need to pay close attention to AbbVie (ABBV) stock based on the movements in the options market lately. | Are Options Traders Betting on a Big Move in AbbVie (ABBV) Stock? | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-12-22 08:30:00 | https://seekingalpha.com/article/4395763-new-covid-strain-leads-to-new-worries-5-high-yield-dividend-stocks-are-still-safe | A new COVID strain has been found in Great Britain, its transmission rate is up to 70% higher. This could lead to harsher lockdowns and more interruptions to businesses. | New COVID Strain Leads To New Worries: 5 High-Yield Dividend Stocks That Are Still Safe | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-12-21 09:03:01 | https://seekingalpha.com/article/4395610-dgi-for-diy-q3-2020-dividend-portfolio-update | Dividend growth moderated in Q3, as portfolio income growth dropped to 4.5%. Two trades were made following dividend cuts from Dominion Energy and Wells Fargo. | DGI For The DIY: Q3 2020 Dividend Portfolio Update | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-12-21 00:28:21 | https://seekingalpha.com/article/4395553-2-fast-growing-buffett-blue-chip-bargains-are-11-of-retirement-portfolio | These 2 Fast-Growing Buffett Blue-Chip Bargains Are 11% Of My Retirement Portfolio | These 2 Fast-Growing Buffett Blue-Chip Bargains Are 11% Of My Retirement Portfolio | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-12-20 15:01:41 | https://seekingalpha.com/article/4395526-week-in-review-weeks-china-life-science-investments-total-800-million | Overland Pharmaceuticals will form a $117 million China JV with Allogene Therapeutics to bring allogenic CAR-T drugs to China. Harbour BioMed has out-licensed its fully human SARS-CoV-2 neutralizing antibody, 47D11, to AbbVie. | Week In Review: Week's China Life Science Investments Total $800 Million | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-12-17 07:03:00 | https://www.fool.com/investing/2020/12/17/3-dividend-stocks-id-buy-right-now/ | These three stocks can provide dividend investors with a solid and safe yield and consistent growth. And all three are available at a bargain, for the time being. | 3 Dividend Stocks I'd Buy Right Now | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2020-12-16 18:48:18 | https://www.zacks.com/stock/news/1173806/abbvie-abbv-outpaces-stock-market-gains-what-you-should-know | In the latest trading session, AbbVie (ABBV) closed at $104.64, marking a +1.77% move from the previous day. | AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-12-15 16:35:21 | https://seekingalpha.com/article/4394921-november-buys-3-monthly-paying-cefs-plus-dividend-growth-opportunities | November started out with a bang due to the election. Besides some early buying last month, it was another month of light buying throughout the remainder of November. | November Buys: 3 Monthly Paying CEFs, Plus Some Dividend Growth Opportunities | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Invezz | 2020-12-15 14:55:24 | https://invezz.com/news/2020/12/15/abbvie-shares-remain-in-focus-for-investors-after-the-company-increased-the-dividend-by-10-2/ | AbbVie (NYSE: ABBV) shares have advanced from $80 above $109 since the beginning of November, and the current price stands around $103. The company has reported better than expected results in Q3 and increased the quarterly dividend by 10.2%. | Abbvie shares remain in focus for investors after the company increased the dividend by 10.2% | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
CNBC Television | 2020-12-15 13:31:51 | https://www.youtube.com/watch?v=mbbw5fIE094 | The "Halftime Report" traders give their top picks to watch for the second half. | Final Trades: AMD, AbbVie, Wingstop & more | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo Finance | 2020-12-14 20:33:51 | https://www.youtube.com/watch?v=2YDnF3BMX7w | Warren Buffett's Berkshire Hathaway released its newest holdings worth more than $1.8 billion with notable investments in some big pharma stocks like Merck and Pfizer. Yahoo Finance's Jared Blikre breaks it all down. | Warren Buffett's Berkshire Hathaway has new stakes in AbbVie, Pfizer, Merck, Bristol-Myers Squibb | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GuruFocus | 2020-12-14 14:38:46 | https://www.gurufocus.com/news/1310730/3-health-care-companies-that-recently-raised-dividends | Dividend increase announcements continue to pile up as 2020 draws to a close. The health care sector remains one of my favorite places to find stocks offering solid yields and lengthy track records of dividend growth. | 3 Health Care Companies That Recently Raised Dividends | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-12-13 15:29:26 | https://seekingalpha.com/article/4394475-ride-through-another-covid-wave-5-undervalued-dividend-growth-stocks | Another wave of COVID wave is upon us, with cases in various states rising to new record levels and shutdowns proliferating. Dividend Growth Stocks have historically offered reliable income that can see you through tough times. They have a history of outperforming during recessions and market troubles. | Ride Through Another COVID Wave With These 5 Undervalued Dividend Growth Stocks | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-12-12 08:10:00 | https://www.fool.com/investing/2020/12/12/2-high-yielding-dividend-stocks-to-buy-if-the-mark/ | Things are looking up, but investors who prepare now for another nosedive may find great returns in these two companies. | 2 High-Yielding Dividend Stocks to Buy if the Market Crashes Again | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-12-11 16:21:41 | https://seekingalpha.com/article/4394350-abbvie-no-sense-of-post-humira-failure-price-target-is-120-150 | AbbVie stock has surged since my last post, gaining 28% to trade at $107 at the time of writing. Q320 results returned the company to profitability - an impressive achievement given the integration of Allergan assets and pandemic pressures. | AbbVie: No Sense Of (Post) Humira Failure - My Price Target Is $120 - $150 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
PRNewsWire | 2020-12-11 07:32:00 | https://www.prnewswire.com/news-releases/chmp-recommends-the-approvals-of-rinvoq-upadacitinib-for-the-treatment-of-adults-with-active-psoriatic-arthritis-and-ankylosing-spondylitis-301191192.html | NORTH CHICAGO, Ill., Dec. 11, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the approval of RINVOQ™ (upadacitinib, 15 mg), an oral, once daily selective and reversible... | CHMP Recommends the Approvals of RINVOQ™ (Upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis and Ankylosing Spondylitis | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
24/7 Wall Street | 2020-12-10 09:50:15 | https://247wallst.com/healthcare-business/2020/12/10/5-dividend-paying-pharmaceutical-stocks-to-buy-for-solid-2021-total-return/ | Many prognosticators across Wall Street feel that interest rates will start to rise in 2021 Deutsche Bank is negative on duration and sees the 10-year Treasury bond yield rising to 1.5% in the second quarter of 2021 from the current yield of 0.95%. | 5 Dividend-Paying Pharmaceutical Stocks to Buy for Solid 2021 Total Return | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-12-10 00:17:00 | https://www.fool.com/investing/2020/12/10/the-only-warren-buffett-stock-worth-buying/ | Forget the rest. There's only one you need to focus on. | The Only Warren Buffett Stock Worth Buying | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-12-08 04:38:01 | https://seekingalpha.com/article/4393529-pfizer-vs-merck-vs-abbvie-vs-bristol-myers-vs-johnson-johnson-vs-amgen | Healthcare stocks are a staple of every portfolio. With an ageing population, healthcare stocks are here to stay. | Pfizer Vs. Merck Vs. AbbVie Vs. | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-12-07 16:47:10 | https://seekingalpha.com/article/4393448-alector-al001s-phase-3-initiation-phase-2-readout-in-2021-462m-in-cash-and-abbvies-promising | Alector, Inc (Nasdaq: ALEC) is a clinical-stage biopharmaceutical company focused on immuno-neurology, immune dysfunction studies related to degenerative brain disorders. Alector has 4-clinical phase therapeutics entirely targeting primarily neurological diseases including Alzheimer's and Frontotemporal Dementia. Alect... | Alector: AL001's Phase 3 Initiation/Phase 2 Readout In 2021, $462M In Cash, And AbbVie's Promising Support, +38% Upside | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-12-07 16:26:45 | https://seekingalpha.com/article/4393451-4-buffett-fat-pitch-high-yield-blue-chip-bargains-set-to-soar | Just because the S&P 500 is 40% historically overvalued, doesn't mean you can't still find plenty of Buffett style "fat pitch" high-yield blue-chip bargains. 9/12 quality blue-chip BTI yields a safe 7.2%, is 51% undervalued, and analysts expect it could deliver 5-year total returns of 20.5% CAGR, 7.3X that of the S&P 5... | 4 Buffett Fat Pitch High-Yield Blue-Chip Bargains Set To Soar | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2020-12-07 13:46:51 | https://investorplace.com/2020/12/seven-medical-marijuana-stocks-for-a-healthcare-revolution/ | Medicinal cannabis is no longer speculative. There are truly impactful treatments out there, as well as investment-worthy marijuana stocks. | 7 Medical Marijuana Stocks for a Healthcare Revolution | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2020-12-07 05:01:05 | https://investorplace.com/2020/12/7-cheap-stocks-to-buy-before-the-market-realizes-their-worth-abbv-t-qcom-gs-nls-f/ | Almost everyone likes cheap stocks, because as investors, we don't like to overpay. Some are value traps, while others are treasure chests. | 7 Cheap Stocks to Buy Before the Market Realizes their Worth | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
PRNewsWire | 2020-12-06 13:00:00 | https://www.prnewswire.com/news-releases/combined-data-from-multiple-phase-3-studies-of-imbruvica-ibrutinib-show-efficacy-and-safety-in-high-risk-previously-untreated-chronic-lymphocytic-leukemia-cll-and-real-world-data-indicating-low-biomarker-testing-rates-for-th-301186846.html | NORTH CHICAGO, Ill., Dec. 6, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), today announced results from a long-term integrated analysis of two Phase 3 clinical studies and additional pooled analysis evaluating the effect of IMBRUVICA (ibrutinib) based therapies for the first-line treatment of... | Combined Data from Multiple Phase 3 Studies of IMBRUVICA® (ibrutinib) Show Efficacy and Safety in High-Risk, Previously Untreated Chronic Lymphocytic Leukemia (CLL) and Real-World Data Indicating Low Biomarker Testing Rates for These Patients | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-12-06 06:12:00 | https://www.fool.com/investing/2020/12/06/3-value-stocks-warren-buffett-owns-that-you-should/ | The Oracle of Omaha knows a good bargain when he sees one. | 3 Value Stocks Warren Buffett Owns That You Should Consider Buying Too | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
PRNewsWire | 2020-12-05 12:45:00 | https://www.prnewswire.com/news-releases/abbvie-presents-extended-follow-up-data-for-fixed-duration-treatment-venclextavenclyxto-venetoclax-in-chronic-lymphocytic-leukemia-cll-301186833.html | NORTH CHICAGO, Ill., Dec. 5, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced new, updated results from the Phase 3 MURANO and CLL14 clinical trials evaluating VENCLEXTA®/VENCLYXTO® (venetoclax) fixed duration treatment combinations at the virtual 62nd American Society of... | AbbVie Presents Extended Follow-Up Data for Fixed Duration Treatment VENCLEXTA®/VENCLYXTO® (venetoclax) in Chronic Lymphocytic Leukemia (CLL) | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
PRNewsWire | 2020-12-05 12:30:00 | https://www.prnewswire.com/news-releases/imbruvica-ibrutinib-plus-venclextavenclyxto-venetoclax-combination-shows-high-rates-of-disease-free-survival-one-year-post-treatment-in-previously-untreated-patients-with-chronic-lymphocytic-leukemia-cll-301186821.html | NORTH CHICAGO, Ill., Dec. 5, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced new data from the Phase 2 CAPTIVATE (PCYC-1142) clinical trial evaluating IMBRUVICA® (ibrutinib) in combination with VENCLEXTA®/VENCLYXTO® (venetoclax) in previously untreated patients with chronic... | IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Combination Shows High Rates of Disease-Free Survival One Year Post-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL) | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2020-12-03 13:53:40 | https://investorplace.com/2020/12/3-dividend-stocks-for-big-total-returns-in-2021-abbv-jnj-mdt/ | These dividend stocks continue to outperform thier competition in yielding higher and consistent returns despite the impact of the pandemic The post 3 Dividend Stocks for Big Total Returns in 2021 appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals... | 3 Dividend Stocks for Big Total Returns in 2021 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-12-03 13:17:05 | https://seekingalpha.com/article/4392835-abbvie-inc-abbv-presents-piper-sandler-32nd-annual-healthcare-conference-transcript | AbbVie Inc. (ABBV) Presents at Piper Sandler 32nd Annual Healthcare Conference (Transcript) | AbbVie Inc. (ABBV) Presents at Piper Sandler 32nd Annual Healthcare Conference (Transcript) | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-12-02 19:45:57 | https://seekingalpha.com/article/4392665-abbvie-abbv-management-on-evercore-isi-3rd-annual-healthconx-conference | AbbVie (ABBV) Management on Evercore ISI 3rd Annual HealthCONx Conference | AbbVie (ABBV) Management on Evercore ISI 3rd Annual HealthCONx Conference | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2020-12-01 13:01:43 | https://investorplace.com/2020/12/4-pharmaceutical-stocks-ino-regn-abbv-nvax-that-arent-worth-their-2020-gains/ | Now that companies such as Pfizer, Moderna and AstraZeneca have emerged with viable vaccines against Covid-19, the hype around many pharmaceutical stocks is fading. Here are four stocks investors should be weary of in the weeks ahead. | 4 Pharmaceutical Stocks That Aren't Worth Their Outsized 2020 Gains | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-12-01 11:01:20 | https://seekingalpha.com/article/4392293-buffett-buys-pharma-two-out-of-four-seem-compelling | Berkshire's latest filing revealed the Oracle of Omaha and his team opening new positions in four pharma giants as of late. From a quality standpoint, all companies seem like a natural fit considering Buffett's reported preference for wide-moat businesses. | Buffett Buys Pharma: Two Out Of Four Seem Compelling | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-12-01 08:39:00 | https://www.fool.com/investing/2020/12/01/3-pharma-stocks-with-dividends-above-4-to-buy-now/ | Should you buy these drugmaker stocks for their juicy dividend yields? | 3 Pharma Stocks With Dividends Above 4% to Buy Now | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Forbes | 2020-12-01 07:00:00 | https://www.forbes.com/sites/greatspeculations/2020/12/01/despite-a-65-rally-abbvie-stock-looks-like-it-can-gain-more/ | AbbVie stock is up 18% since the start of the year and it has gained around 62% from its March lows. Despite the recent rally, AbbVie could offer an upside in the near term, as the company's revenues in the last three quarters have grown by 30%, primarily aided by the Allergan acquisition. | Despite A 65% Rally AbbVie Stock Looks Like It Can Gain More | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-11-30 12:09:54 | https://seekingalpha.com/article/4392066-eighth-review-of-dividend-portfolio | Top five holdings add up to 50% of my portfolio. Portfolio currently yields approximately 3.91%. | Eighth Review Of My Dividend Portfolio | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GuruFocus | 2020-11-29 08:25:10 | https://www.gurufocus.com/news/1298016/berkshire-hathaway-makes-big-bet-on-pharma | Despite solid gains in pharma sales and profits, Big Pharma's overall share value has pretty much stagnated over the past five years—but better days appear to be ahead, in my opinion. | Berkshire Hathaway Makes Big Bet on Pharma | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-11-28 06:24:00 | https://www.fool.com/investing/2020/11/28/is-abbvie-a-great-dividend-stock/ | The stock has a high yield -- and it also has something even more important. | Is AbbVie a Great Dividend Stock? | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-11-27 06:02:21 | https://seekingalpha.com/article/4391757-dividend-cornucopia-of-39-november-kiplinger-analyst-favorites | In October and July, Kiplinger Today listed Analyst and Kiplinger favorite dividend stocks. Analyst October favorites numbered 25, plus 15 from Kiplinger, with one repeated left 39 total. These 39 stocks ranged from 1.42% to 8.74% in annual yield and ranged from 0.13% to 33.33% in one-year price target upsides per brok... | A Dividend Cornucopia Of 39 November Kiplinger/Analyst Favorites | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Insider Monkey | 2020-11-27 05:33:20 | https://www.insidermonkey.com/blog/top-10-stocks-warren-buffett-just-bought-892035/ | In this article we'll run through the Top 10 Stocks Warren Buffett Just Bought. If you're in a hurry to see the hedge fund legend's highest conviction new stock purchases, you can jump straight to the Top 5 Stocks Warren Buffett Just Bought . | Top 10 Stocks Warren Buffett Just Bought | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga | 2020-11-25 13:48:37 | https://www.benzinga.com/trading-ideas/long-ideas/20/11/18536752/3-dividend-aristocrats-for-safe-dividends-and-high-total-returns | By Bob Ciura with Sure Dividend. The U.S. stock market has come roaring back from the lows seen in March and April, but the broader economy remains on unstable footing. | 3 Dividend Aristocrats For Safe Dividends And High Total Returns | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2020-11-25 07:22:00 | https://www.marketwatch.com/story/only-these-five-dividend-stocks-made-the-cut-in-a-safer-and-better-screen-11606258156 | The companies had to reach yield and sales hurdles. | Deep Dive: Only these five dividend stocks made the cut in a ‘safer and better' screen | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-11-22 06:08:00 | https://www.fool.com/investing/2020/11/22/these-3-dividend-stocks-are-practically-money-mach/ | You can likely count on these dividends flowing for a long time to come. | These 3 Dividend Stocks Are Practically Money Machines | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-11-21 08:30:00 | https://seekingalpha.com/article/4390782-dividend-growth-up-to-18-aristocrats-deliver-during-pandemic | Dividend Aristocrats have proven to be reliable investments, no matter what the macro environment looks like. Some of them have continued to raise the dividend at an attractive pace during this pandemic. | Dividend Growth Up To 18%: These Aristocrats Deliver During The Pandemic | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-11-21 07:30:00 | https://www.fool.com/investing/2020/11/21/like-dividends-i-bet-youll-love-these-3-stocks/ | These companies are not only well established, but they takes their payout's reliable growth seriously. | Like Dividends? I Bet You'll Love These 3 Stocks | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-11-21 06:12:00 | https://www.fool.com/investing/2020/11/21/3-high-yield-dividend-stocks-to-buy-now/ | These companies are increasing their dividends at a time when their yields are already very attractive. | 3 High-Yield Dividend Stocks to Buy Now | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-11-20 08:01:00 | https://www.fool.com/investing/2020/11/20/warren-buffett-just-bought-these-stocks/ | Berkshire Hathaway's 13-F filing shows the Oracle of Omaha's bullish on healthcare. | Warren Buffett Just Bought These Stocks | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-11-19 14:36:04 | https://seekingalpha.com/article/4390402-abbvie-inc-abbv-presents-wolfe-research-healthcare-conference-transcript | AbbVie Inc. (ABBV) Presents at Wolfe Research Healthcare Conference (Transcript) | AbbVie Inc. (ABBV) Presents at Wolfe Research Healthcare Conference (Transcript) | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-11-19 08:30:08 | https://seekingalpha.com/article/4390204-5-yielding-abbvie-double-digit-dividend-raise-and-buffett-endorsement | AbbVie reported strong Q3 results, the pandemic is not a major headwind for the company. Following another double-digit dividend raise, AbbVie's dividend yield is 5.2%. | 5%-Yielding AbbVie: Double-Digit Dividend Raise And A Buffett Endorsement | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-11-19 01:44:33 | https://seekingalpha.com/article/4390203-abbvie-should-benefit-from-buffett-bounce | ABBV is a large biopharmaceutical corporation whose main drug is Humira. ABBV acquired Allergan last year, which provided it with diversification, as well as more substantial size and scale. | AbbVie Should Benefit From A Buffett Bounce | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
PRNewsWire | 2020-11-18 17:00:00 | https://www.prnewswire.com/news-releases/abbvie-announces-expiration-and-final-results-of-registered-exchange-offers-301176491.html | NORTH CHICAGO, Ill., Nov. 18, 2020 /PRNewswire/ -- AbbVie Inc. (NYSE:ABBV) ("AbbVie") announced today the expiration and final results of its offers to exchange (the "Registered Exchange Offers") any and all of its outstanding (i) $30,000,000,000 aggregate principal amount of senior... | AbbVie Announces Expiration and Final Results of Registered Exchange Offers | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Insider | 2020-11-18 08:28:57 | https://www.businessinsider.com/warren-buffett-berkshire-hathaway-buy-4-pharma-stocks-20-years-2020-11 | Warren Buffett's Berkshire Hathaway plowed more than $5 billion in total into AbbVie, Bristol Myers Squibb, Merck, and Pfizer in the third quarter. Close followers of the company won't be surprised, as Buffett has been mulling a bet on the pharmaceutical sector for more than 20 years. "You could've just bought the whol... | Warren Buffett's Berkshire Hathaway plowed more than $5 billion into 4 pharma stocks last quarter. He's been teasing a bet on the sector for more than 20 years | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-11-18 06:08:00 | https://www.fool.com/investing/2020/11/18/heres-exactly-why-warren-buffett-loaded-up-on-big/ | The Oracle of Omaha and his investing lieutenants knew what they were doing in buying AbbVie, BMS, Merck, and Pfizer. | Here's Exactly Why Warren Buffett Loaded Up on Big Pharma Stocks | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-11-17 12:28:00 | https://www.fool.com/investing/2020/11/17/despite-buffett-bullishness-stock-markets-are-fall/ | Find out what the Oracle of Omaha's company has been buying lately. | Despite Buffett Bullishness, Stock Markets Are Falling | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Insider | 2020-11-17 07:13:00 | https://www.businessinsider.com/abbvie-merck-pfizer-stock-price-warren-buffett-berkshire-hathaway-pharmaceuticals-2020-11 | AbbVie, Merck, Bristol Myers Squibb, and Pfizer are the latest beneficiaries of the "Buffett Effect." The quartet of pharmaceutical stocks jumped in pre-market trading on Tuesday after Warren Buffett's Berkshire Hathaway revealed on Monday that it invested in them last quarter. AbbVie, Merck, and Pfizer gained as much ... | AbbVie, Merck, and Pfizer shares jump after Warren Buffett's Berkshire Hathaway reveals it bought them last quarter | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-11-16 18:54:44 | https://www.fool.com/investing/2020/11/16/warren-buffett-bought-4-pharma-giants-in-q3/ | The Oracle of Omaha and his team opened new positions in the underperforming sector. | Warren Buffett Bought 4 Pharma Giants in Q3 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
CNN Business | 2020-11-16 17:28:14 | https://www.cnn.com/2020/11/16/investing/warren-buffett-berkshire-hathaway-drug-stocks/index.html | Warren Buffett's Berkshire Hathaway is making a big bet on the health care sector at a time when the Covid-19 pandemic continues to be a major crisis in the United States. | Warren Buffett's Berkshire Hathaway makes big bets on drug stocks | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2020-11-16 10:28:45 | https://www.fool.com/investing/2020/11/16/3-recession-proof-stocks-to-buy-now/ | Investors worried about a recession should consider leading stocks in the utilities, basic consumer goods, and healthcare sectors. | 3 Recession Proof Stocks to Buy Now | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-11-16 08:55:28 | https://seekingalpha.com/article/4389264-value-vs-growth-buy-5-top-dividend-stocks-you-want | Sometimes investors think they need to choose between value and growth, you can have both. However, in dividend investing, you often have to choose between value, yield and growth. | Value Vs. Growth: Buy These 5 Top Dividend Stocks If You Want Both | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2020-11-13 09:33:21 | https://seekingalpha.com/article/4388819-dividend-income-summary-lannys-october-2020-summary | In October, we (my wife and I) received a total of $839.12 of dividend income. We had two massive dividend payments that came in from Philip Morris and Canadian Imperial. | Dividend Income Summary: Lanny's October 2020 Summary | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.